Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:36 pm Purchase | 2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 626,862 9.990% | 61,378 (+10.85%) | Filing History |
| 2024-06-18 4:30 pm Unchanged | 2024-06-14 | 13D | Aytu BioPharma, Inc. AYTU | Nantahala Capital Management LLC | 1,086,812 18.200% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:25 pm Purchase | 2023-12-31 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 565,484 9.990% | 1,642 (+0.29%) | Filing History |
| 2023-06-16 5:14 pm Purchase | 2023-06-13 | 13D | Aytu BioPharma, Inc. AYTU | Nantahala Capital Management LLC | 1,086,812 19.700% | 815,217 (+300.16%) | Filing History |
| 2023-06-16 4:48 pm Purchase | 2023-06-09 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 563,842 9.990% | 563,842 (New Position) | Filing History |
| 2023-05-26 1:52 pm Purchase | 2023-05-26 | 13D | Aytu BioPharma, Inc. AYTU | Nantahala Capital Management LLC | 271,595 7.200% | 271,595 (New Position) | Filing History |
| 2023-02-14 11:23 am Purchase | 2022-12-31 | 13G | Aytu BioPharma, Inc. AYTU | CVI Investments, Inc. | 3,278,844 4.900% | 3,278,844 (New Position) | Filing History |
| 2022-08-15 10:01 am Purchase | 2022-08-10 | 13G | Aytu BioPharma, Inc. AYTU | CVI Investments, Inc. | 68,000,000 5.600% | 68,000,000 (New Position) | Filing History |
| 2022-02-11 3:29 pm Sale | 2021-12-31 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 0 0.000% | -27,975,520 (Position Closed) | Filing History |
| 2021-09-01 4:25 pm Purchase | 2021-09-01 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 27,530,900 4.900% | 683,340 (+2.55%) | Filing History |
| 2021-08-31 4:32 pm Purchase | 2021-08-30 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 26,847,560 5.300% | 26,847,560 (New Position) | Filing History |
| 2021-03-26 4:21 pm Purchase | 2021-03-18 | 13G | Aytu BioPharma, Inc. AYTU | Integrated Core Strategies (US) LLC | 457,320 0.100% | 457,320 (New Position) | Filing History |
| 2021-02-12 4:57 pm Purchase | 2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 27,975,520 8.100% | 1,308,840 (+4.91%) | Filing History |
| 2021-02-10 10:45 am Unchanged | 2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU | Altium Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-01-05 11:45 am Purchase | 2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU | SABBY MANAGEMENT, LLC | 14,614,140 11.000% | 14,614,140 (New Position) | Filing History |
| 2020-12-21 5:07 pm Purchase | 2020-12-11 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 26,666,680 7.700% | 25,851,934 (+3173.01%) | Filing History |
| 2020-12-16 6:02 pm Purchase | 2020-12-11 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 26,666,680 7.700% | 26,666,680 (New Position) | Filing History |
| 2020-04-29 5:29 pm Sale | 2020-04-27 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 814,746 0.400% | -9,403,096 (-92.03%) | Filing History |
| 2020-04-27 4:30 pm Unchanged | 2020-04-10 | 13G | Aytu BioPharma, Inc. AYTU | Avalo Therapeutics Inc. AVTX | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-04-08 4:21 pm Purchase | 2020-03-20 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 10,217,842 5.300% | 217,840 (+2.18%) | Filing History |